GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of does SELECT actually matter or is it forum lore at this point — 36 comments in the full submission. View in context.
1.8k
c/trialwatch·submitted 2 months ago by u/joaquin_trevino

does SELECT actually matter or is it forum lore at this point

Trial Databranch of 9 comments

The title is the whole question — does SELECT actually matter or is it forum lore at this point — but here is why I am asking. Went looking for the registered protocol to see whether the endpoint had changed. It had not, which was reassuring and worth checking. Started keeping the trial identifiers straight in a note…

Read the full submission and all 36 comments →

This branch

9 comments, started 2 months ago
u/ferran_dahlberg236 points·2 months ago

The press release said that; the publication says something more hedged. Worth reading both.

replysharereportpermalink
u/joaquin_trevinoOP275 points·2 months ago

Correcting myself upthread: I gave the completer figure and labelled it intention-to-treat.

replysharereportpermalink
u/ines_boateng-15 points·2 months ago

Disagree — that figure is from the diabetes programme and you are quoting it as an obesity endpoint.

replysharereportpermalink
u/karl_fischer_kev1 point·2 months ago

Quoted a figure here confidently, got asked whether it was ITT, went and checked, and it was not. Learned something.

replysharereportpermalink
u/slow_logbook_notes301 point·2 months ago

SELECT was cardiovascular outcomes, not weight

replysharereportpermalink
u/arne_ilunga281 points·2 months ago

the appendix is where the interesting tables live

replysharereportpermalink
u/nayeli_fonseca235 points·2 months ago

The discontinuation numbers were the most useful thing in the paper for me and they were in a supplementary table.

replysharereportpermalink
u/ms_fragmenter394 points·2 months ago

Spent an evening with the appendix tables and found the subgroup detail that the entire thread had been speculating about.

replysharereportpermalink
u/customs_seizure_sid538 points·2 months ago

Cardiovascular outcome trials are powered for events, not for weight, and are typically run in a different population with different inclusion criteria. Reading a weight number out of one is reading a secondary endpoint.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.